Monthly Archives: July 2023

Former Pfizer employee charged with Covid drug insider trading

Covid drug insider trading

A former employee of pharmaceutical company Pfizer has been charged with insider trading related to the company’s Covid-19 drug. The United States Securities and Exchange Commission (SEC) charged the former employee, Sungjae “Jay” Lee, with making illegal trades based on non-public information about the company’s Covid-19 treatment. According to the SEC, Lee worked as a senior associate in Pfizer’s statistical ...

Read More »